GMSbiotech Overview

  • Founded
  • 2002

Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3M

  • Investors
  • 6

GMSbiotech General Information

Description

Developer of microarray test kits intended for various DNA and protein-based disease state applications. The company provides Human Leukocyte Antigen typing for transplantation, which is responsible for detecting foreign substances and triggering the immune system, providing healthcare professionals products that are easy to use, cost-effective, require no upfront sample prep, and provide high-quality resolution.

Contact Information

Website
www.gmsbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 2018 Westvalley Place
  • Round Rock, TX 78665
  • United States
+1 (877) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GMSbiotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Grant 01-Feb-2018 $3M 00000 Completed Generating Revenue
9. Grant 01-Feb-2016 00.000 00000 Completed Generating Revenue
8. Angel (individual) 01-Jun-2014 00000 Completed Generating Revenue
7. Grant 01-Aug-2013 00.000 00000 Completed Generating Revenue
6. Equity Crowdfunding 11-Jun-2013 00000 00000 Completed Generating Revenue
5. Grant 09-Aug-2011 00000 Completed Generating Revenue
4. Grant 01-Jan-2009 00.000 Completed Generating Revenue
3. Angel (individual) Completed Generating Revenue
2. Grant 01-Jan-2006 $2.8M Completed Generating Revenue
1. Grant 01-Jan-2004 $499K Completed Startup
To view GMSbiotech’s complete valuation and funding history, request access »

GMSbiotech Patents

  • 42

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

GMSbiotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210317528-A1 Blood typing using dna Inactive 23-Jul-2018 0000000000 0
US-20200080146-A1 Methods for pcr and hla typing using unpurified samples Inactive 16-Nov-2009 0000000000
AU-2016266065-A1 Methods for pcr and hla typing using raw blood Active 16-Nov-2009 0000000000
AU-2010318721-A1 Methods for pcr and hla typing using raw blood Inactive 16-Nov-2009 0000000000
AU-2016266065-B2 Methods for pcr and hla typing using raw blood Active 16-Nov-2009 C12Q1/6881
To view GMSbiotech’s complete patent history, request access »

GMSbiotech Executive Team (4)

Name Title Board Seat Contact Info
Krishna Jayaraman Ph.D Co-Founder, Chief Executive Officer, Chairman & President
Michael Hogan Ph.D Co-Founder & Board Member
You’re viewing 2 of 4 executive team members. Get the full list »

GMSbiotech Board Members (5)

Name Representing Role Since
GS Arora Self Board Member 000 0000
Krishna Jayaraman Ph.D GMSbiotech Co-Founder, Chief Executive Officer, Chairman & President 000 0000
Maqbool Halepota MD GMSbiotech Board Member 000 0000
Michael Hogan Ph.D GMSbiotech Co-Founder & Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

GMSbiotech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institute Of Allergy and Infectious Diseases Government 000 0000 000000 0
National Heart Blood and Lung Institute Government 000 0000 000000 0
Arizona Tech Investors Angel Group Minority 000 0000 000000 0
Illinois Technology Enterprise Council Other Minority 000 0000 000000 0
Quantrx Biomedical Corporation Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial